reference/31612794

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/31612794

Outgoing Links

Predicate	Object
contentType	Comparative Study\|Journal Article\|Research Support, Non-U.S. Gov't
endingPage	1026
issn	0145-2126
issueIdentifier	8
pageRange	1020-1026
publicationName	Leukemia Research
startingPage	1020
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_4b29b17c00122c416981bb77d6e97e59 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c6cdcbcf232ca31407a90d724f9f66fd
bibliographicCitation	Liu L, Yang L, Mi Y, Wang J, Li J, Zhang Y, Ma X, Qin T, Xu Z, Xiao Z. RAD51 and XRCC3 polymorphisms: impact on the risk and treatment outcomes of de novo inv(16) or t(16;16)/CBFβ-MYH11(+) acute myeloid leukemia. Leuk Res. 2011 Aug;35(8):1020–6. doi: 10.1016/j.leukres.2011.01.014. PMID: 21296419.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f749cfdca0d90dd1b6d4e4932dc98ecc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8f72754edac2a9541c84cdcab98200bf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_65f2d03daf4b4d1ab2cc110ff0261909 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e7765469b69d9efae04152bc2fb88f57 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d0fda6d0445ddc298832f819b552f85e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6e0aefda64fddf7a9fe6c18de7d5b5d6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6712d6f0e84ccdd709c16459c0a15a9e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9615ec600208078d1655de7d94864cb7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d88a5098f00f04732bc853a355d66126 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cbc9ae388827e76e6024bdaf4ddfeac5
date	201108
identifier	https://pubmed.ncbi.nlm.nih.gov/21296419 https://doi.org/10.1016/j.leukres.2011.01.014
isPartOf	https://portal.issn.org/resource/ISSN/0145-2126 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5304
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	RAD51 and XRCC3 polymorphisms: Impact on the risk and treatment outcomes of de novo inv(16) or t(16;16)/CBFβ–MYH11(+) acute myeloid leukemia
discusses	http://id.nlm.nih.gov/mesh/M0251508 http://id.nlm.nih.gov/mesh/M0006678 http://id.nlm.nih.gov/mesh/M0006685 http://id.nlm.nih.gov/mesh/M0023875 http://id.nlm.nih.gov/mesh/M0287372 http://id.nlm.nih.gov/mesh/M0201270 http://id.nlm.nih.gov/mesh/M0201275
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D004268Q000235 http://id.nlm.nih.gov/mesh/D015470Q000235 http://id.nlm.nih.gov/mesh/D011110Q000235 http://id.nlm.nih.gov/mesh/D051135Q000235 http://id.nlm.nih.gov/mesh/D014178 http://id.nlm.nih.gov/mesh/D002885Q000235 http://id.nlm.nih.gov/mesh/D015514Q000235 http://id.nlm.nih.gov/mesh/D007446
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D015470Q000628 http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D055815 http://id.nlm.nih.gov/mesh/D012189 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D004273Q000235 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D002675 http://id.nlm.nih.gov/mesh/D015996 http://id.nlm.nih.gov/mesh/D002648 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D016022 http://id.nlm.nih.gov/mesh/D016133 http://id.nlm.nih.gov/mesh/D005838 http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D012150 http://id.nlm.nih.gov/mesh/D008875
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_53ae890659376293c1b01d3a427d298f http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9091f9d0b2e1bc76ac280a84a8e3f42d http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8937 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4101f7063ae53d6af978fe9fd78f0ec7 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9731

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7517

Total number of triples: 71.